Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-15

Clinical Trial Update: Lubiprostone for Functional Constipation in the Under 18 Years Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lubiprostone for functional constipation in patients under 18 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUBIPROSTONE (lubiprostone)

Snippet

Sponsor: Alexandria University | Conditions: Clinical Efficacy, Treatment Efficacy | Phase 3 | Status: COMPLETED